Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 09, 2022

SELL
$7.9 - $10.19 $83,740 - $108,014
-10,600 Closed
0 $0
Q1 2021

May 06, 2021

SELL
$10.34 - $12.81 $90,992 - $112,728
-8,800 Reduced 45.36%
10,600 $122,000
Q2 2020

Jul 13, 2020

SELL
$8.12 - $13.12 $37,352 - $60,352
-4,600 Reduced 19.17%
19,400 $239,000
Q3 2019

Nov 12, 2019

SELL
$6.16 - $9.6 $17,248 - $26,880
-2,800 Reduced 10.45%
24,000 $165,000
Q2 2019

Aug 05, 2019

SELL
$8.12 - $15.72 $1,623 - $3,144
-200 Reduced 0.74%
26,800 $247,000
Q1 2019

May 03, 2019

SELL
$15.58 - $20.01 $24,928 - $32,016
-1,600 Reduced 5.59%
27,000 $423,000
Q4 2018

Feb 06, 2019

SELL
$14.59 - $23.84 $13,131 - $21,456
-900 Reduced 3.05%
28,600 $441,000
Q2 2018

Jul 10, 2018

BUY
$16.77 - $24.71 $3,354 - $4,942
200 Added 0.68%
29,500 $717,000
Q4 2017

Jan 31, 2018

SELL
$11.23 - $19.1 $30,321 - $51,570
-2,700 Reduced 8.44%
29,300 $555,000
Q3 2017

Oct 30, 2017

BUY
$15.41 - $32.17 $493,120 - $1.03 Million
32,000
32,000 $563,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Investment House LLC Portfolio

Follow Investment House LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment House LLC, based on Form 13F filings with the SEC.

News

Stay updated on Investment House LLC with notifications on news.